Article Versions Notes

Doboszewska U, Sawicki J, Sajnóg A, Szopa A, Serefko A, Socała K, Pieróg M, Nieoczym D, Mlyniec K, Nowak G, et al. Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy—The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene. Cells. 2022; 11(13):1987. https://doi.org/10.3390/cells11131987

Doboszewska, Urszula, Jan Sawicki, Adam Sajnóg, Aleksandra Szopa, Anna Serefko, Katarzyna Socała, Mateusz Pieróg, Dorota Nieoczym, Katarzyna Mlyniec, Gabriel Nowak, and et al. 2022. "Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy—The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene" Cells 11, no. 13: 1987. https://doi.org/10.3390/cells11131987

Doboszewska, U., Sawicki, J., Sajnóg, A., Szopa, A., Serefko, A., Socała, K., Pieróg, M., Nieoczym, D., Mlyniec, K., Nowak, G., Barałkiewicz, D., Sowa, I., & Wlaź, P. (2022). Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy—The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene. Cells, 11(13), 1987. https://doi.org/10.3390/cells11131987